Drug Search Results
Using advanced filters...
Advanced Search [+]

Tubocurarine chloride

Alternative Names: tubocurarine chloride, curare
Latest Update: 2024-04-26
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: nAChR Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Austria | Canada | Colombia | France | Ireland | Italy | Pakistan | Poland | Taiwan

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title